Premium
Differences in clinical course between dementia with Lewy bodies and Alzheimer’s disease
Author(s) -
Hanyu H.,
Sato T.,
Hirao K.,
Kanetaka H.,
Sakurai H.,
Iwamoto T.
Publication year - 2009
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.2008.02388.x
Subject(s) - dementia with lewy bodies , medicine , dementia , discontinuation , cognitive decline , disease , alzheimer's disease , pediatrics , parkinson's disease , parkinsonism
Background and purpose: To investigate whether there may be differences in the clinical course and changes in cognitive progression between dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD). Methods: We compared the time from the first visit to endpoints (discontinuation of visits because of admission, death, or institutionalization) between 56 patients with DLB and 111 patients with AD. Mini‐Mental State Examination (MMSE) scores of patients were every 12 months examined up to 60 months. Results: Dementia with Lewy bodies had a significantly shorter time to reaching endpoints than those with AD (median time; 40 months vs. 52 months, P < 0.0001). The proportion of admission (or death) was significantly higher in DLB than in AD (30% vs. 14%, P < 0.05), while the difference in institutionalization in nursing homes did not reach statistical significance (25% vs. 17%). Rates of longitudinal MMSE score decline for DLB and AD groups were equivalent. Conclusion: Dementia with Lewy bodies had a greater risk of admission (or death) because of most commonly fall‐related injuries and bronchopneumonia than AD, but the two groups did not differ in rate of cognitive decline.